5 manufacturing plants across 4 countries (France, India, Germany, China). We combine control of the glass process with the implementation of GMPs for pharmaceutical primary packaging in all our manufacturing facilities.
We offer a broad range of sizes and finishes in Type I, II, or III, amber and clear glass, as well as innovative added-value services like internal siliconization or protective plastic coatings.
We build long-term relationships with our customers and are responsive, reliable, transparent and highly collaborative. Working closely with customers and researching the latest technologies, we seek specific challenges to address through the research or application of new technology solutions.
We aim to improve and protect the health of patients by providing high quality, reliable and innovative primary glass packaging to our pharmaceutical customers.
SGD Pharma is a global leader in glass pharmaceutical packaging, answering to the needs of a diverse range of markets including parenteral, nasal, and oral drugs, as well as beauty and nutrition.
Stand No. :
Visiter le site webStand No. :
Visiter le site webSucy-en-Brie plant celebrated the first furnace lighting ceremony in 10 years – the result of weeks of hard work modernizing the furnace as part of SGD Pharma’s Sucy Pharma 2025 project.
Strengthened value propositions represent the latest step in SGD Pharma’s commitment to continuous improvement
